The benefits and harms of deprescribing

Medical Journal of Australia

Volumn 201, Issue 7, 2014, Pages 386-389

  Reeve, Emily ^a,b   Shakib, Sepehr ^b   Hendrix, Ivanka ^c   Roberts, Michael S ^a,d   Wiese, Michael D ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

^c REPATRIATION GENERAL HOSPITAL   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL;

ARTICLE; AUSTRALIA; DISEASE COURSE; DRUG COST; HUMAN; INAPPROPRIATE PRESCRIBING; INFORMED CONSENT; LIFE EXPECTANCY; MEDICAL HISTORY; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; PATIENT CARE; PHARMACODYNAMICS; POLYPHARMACY; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAPSE; SIDE EFFECT; SYSTEMATIC REVIEW (TOPIC); TREATMENT WITHDRAWAL; WITHDRAWAL SYNDROME; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; SUBSTANCE WITHDRAWAL SYNDROME;

DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; INAPPROPRIATE PRESCRIBING; POLYPHARMACY; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84908309368     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja13.00200     Document Type: Article

References (30)

1. Woodward MC. Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res 2003; 33: 323-328.
2. Hajjar ER, Cafi ero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007; 5: 345-351.
3. Gnjidic D, Le Couteur DG, Kouladjian L, Hilmer SN. Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med 2012; 28: 237-253.
4. Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007; 370: 173-184.
5. Kaur S, Mitchell G, Vitetta L, Roberts MS. Interventions that can reduce inappropriate prescribing in the elderly: a systematic review. Drugs Aging 2009; 26: 1013-1028.
6. Gurwitz JH, Field TS, Rochon P, et al. Eff ect of computerized provider order entry with clinical decision support on adverse drug events in the long-term care setting. J Am Geriatr Soc 2008; 56: 2225-2233.
7. Hanlon JT, Weinberger M, Samsa GP, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996; 100: 428-437.
8. Mansur N, Weiss A, Beloosesky Y. Relationship of in-hospital medication modifi cations of elderly patients to postdischarge medications, adherence, and mortality. Ann Pharmacother 2008; 42: 783-789.
9. Fuat A, Hungin AP, Murphy JJ. Barriers to accurate diagnosis and eff ective management of heart failure in primary care: qualitative study. BMJ 2003; 326: 196.
10. Iyer S, Naganathan V, McLachlan AJ, Le Couteur DG. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging 2008; 25: 1021-1031.
11. McKellar GE, Hampson R, Tierney A, et al. Nonsteroidal antiinfl ammatory drug withdrawal in patients with stable rheumatoid arthritis. J Rheumatol 2011; 38: 2150-2152.
12. Ekbom T, Lindholm LH, Odén A, et al. A 5-year prospective, observational study of the withdrawal of antihypertensive treatment in elderly people. J Intern Med 1994; 235: 581-588.
13. Ballard C, Hanney ML, Theodoulou M, et al. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol 2009; 8: 151-157.
14. Kersten H, Molden E, Tolo IK, et al. Cognitive eff ects of reducing anticholinergic drug burden in a frail elderly population: a randomized controlled trial. J Gerontol A Biol Sci Med Sci 2013; 68: 271-278.
15. Kemp A, Preen DB, Glover J, et al. How much do we spend on prescription medicines? Out-of-pocket costs for patients in Australia and other OECD countries. Aust Health Rev 2011; 35: 341-349.
16. Eckert KA, Shi Z, Taylor AW, et al. Learning from an epidemiological, population-based study on prescribed medicine use in adults. Pharmacoepidemiol Drug Saf 2013; 22: 271-277.
17. Reeve E, Wiese MD. Benefi ts of deprescribing on patients’ adherence to medications. Int J Clin Pharm 2014; 36: 26-29.
18. Reeve E, Wiese MD, Hendrix I, et al. People’s attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. J Am Geriatr Soc 2013; 61: 1508-1514.
19. Reeve E, To J, Hendrix I, et al. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging 2013; 30: 793-807.
20. Bain KT, Holmes HM, Beers MH, et al. Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process. J Am Geriatr Soc 2008; 56: 1946-1952.
21. Graves T, Hanlon JT, Schmader KE, et al. Adverse events after discontinuing medications in elderly outpatients. Arch Intern Med 1997; 157: 2205-2210.
22. Gerety MB, Cornell JE, Plichta DT, Eimer M. Adverse events related to drugs and drug withdrawal in nursing home residents. J Am Geriatr Soc 1993; 41: 1326-1332.
23. Marcum ZA, Pugh MJV, Amuan ME, et al. Prevalence of potentially preventable unplanned hospitalizations caused by therapeutic failures and adverse drug withdrawal events among older veterans. J Gerontol A Biol Sci Med Sci 2012; 67: 867-874.
24. Uijtendaal EV, Zwart-van Rijkom JE, van Solinge WW, Egberts TC. Serum potassium infl uencing interacting drugs: risk-modifying strategies also needed at discontinuation. Ann Pharmacother 2012; 46: 176-182.
25. Parsons C, Hughes CM, Passmore AP, Lapane KL. Withholding, discontinuing and withdrawing medications in dementia patients at the end of life: a neglected problem in the disadvantaged dying? Drugs Aging 2010; 27: 435-449.
26. Doody RS, Geldmacher DS, Gordon B, et al. Open-label, multicenter, phase 3 extension study of the safety and effi cacy of donepezil in patients with Alzheimer disease. Arch Neurol 2001; 58: 427-433.
27. Black DM, Schwartz AV, Ensrud KE, et al. Eff ects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA 2006; 296: 2927-2938.
28. Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med 2010; 170: 1648-1654.
29. Beer C, Loh Pk, Peng YG, et al. A pilot randomized controlled trial of deprescribing. Ther Adv Drug Saf 2011; 2: 37-43.
30. Reeve E, Shakib S, Hendrix I, et al. Review of deprescribing processes and development of an evidence based, patient-centred deprescribing process. Brit J Clin Pharm 2014; Mar 25. [Epub ahead of print]. doi: 10.1111/ bcp.12386.